Serum gamma-glutamyl transpeptidase-to-platelet ratio (GPR) can predict the prognosis of hepatocellular carcinoma: a meta-analysis and systematic review

BACKGROUND: The relationship between serum gamma-glutamyl transpeptidase-to-platelet ratio (GPR) before treatment and the prognosis of patients with hepatocellular carcinoma (HCC) is unclear. Here, we review and summarize existing data and try to determine the predictive value of GPR in the treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Chenhui, Wang, Na, Ma, Huanhuan, Song, Kewei, Yu, Rong, Chen, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091007/
https://www.ncbi.nlm.nih.gov/pubmed/35571666
http://dx.doi.org/10.21037/tcr-21-2559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091007/
https://www.ncbi.nlm.nih.gov/pubmed/35571666
http://dx.doi.org/10.21037/tcr-21-2559

Ejemplares similares